Fulcrum Therapeutics Cash from Financing (Quarterly) Trends

Fulcrum Therapeutics Inc (FULC)

3.25 +0.28 (+9.43%) USD | NASDAQ | Nov 22, 16:00

3.25 0.00 (0.00%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2018. Upgrade now.

Date	Value
September 30, 2024	0.635M
June 30, 2024	0.377M
March 31, 2024	1.651M
December 31, 2023	0.287M
September 30, 2023	0.00
June 30, 2023	0.142M
March 31, 2023	117.69M
December 31, 2022	0.218M
September 30, 2022	80.95M
June 30, 2022	2.811M
March 31, 2022	0.348M
December 31, 2021	0.891M
September 30, 2021	137.90M
June 30, 2021	0.209M

Date	Value
March 31, 2021	47.50M
December 31, 2020	6.255M
September 30, 2020	-0.083M
June 30, 2020	64.69M
March 31, 2020	0.274M
December 31, 2019	-0.281M
September 30, 2019	65.20M
June 30, 2019	-0.529M
March 31, 2019	-0.047M
December 31, 2018	-0.09M
September 30, 2018	79.82M
June 30, 2018	12.65M
March 31, 2018	12.64M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

-0.281M

Minimum

Dec 2019

137.90M

Maximum

Sep 2021

23.12M

Average

0.506M

Median

Cash from Financing (Quarterly) Benchmarks

Bioventus Inc	0.362M
Johnson & Johnson	-9.882B
Pfizer Inc	-4.636B
Tenon Medical Inc	9.641M
Arcturus Therapeutics Holdings Inc	0.693M

Cash from Financing (Quarterly) Related Metrics

Cash from Operations (Quarterly)	-19.07M
Cash from Investing (Quarterly)	4.35M
Free Cash Flow	-8.739M
Free Cash Flow Per Share (Quarterly)	-0.3059
Free Cash Flow Yield	-4.30%